OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 26-50 of 91 citing articles:

Interventions for the management of post-COVID-19 condition (long COVID): protocol for a living systematic review and network meta-analysis
Dena Zeraatkar, King‐Hwa Ling, Sarah Kirsh, et al.
BMJ Open (2025) Vol. 15, Iss. 2, pp. e086407-e086407
Open Access

Rehabilitation beim Long-/Post-COVID-Syndrom: ein bewegungstherapeutisches Handlungskonzept
Maximilian Köppel, Uwe Schwan, Stefan Peters, et al.
B&G Bewegungstherapie und Gesundheitssport (2025) Vol. 41, Iss. 01, pp. 14-29
Closed Access

Cognitive Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome—Aetiology and Potential Treatments
Amolak S. Bansal, Katharine A. Seton, J.C. Brooks, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1896-1896
Open Access

Health-related quality of life in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Post COVID-19 Condition: a systematic review
Breanna Weigel, Maira Inderyas, Natalie Eaton-Fitch, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access

Protracted stress-induced hypocortisolemia may account for the clinical and immune manifestations of Long COVID
Maria P. Yavropoulou, George C. Tsokos, George P. Chrousos, et al.
Clinical Immunology (2022) Vol. 245, pp. 109133-109133
Open Access | Times Cited: 24

Epstein–Barr virus-acquired immunodeficiency in myalgic encephalomyelitis—Is it present in long COVID?
Manuel Ruiz-Pablos, Bruno Paiva, Aintzane Zabaleta
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 13

Why the Psychosomatic View on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Is Inconsistent with Current Evidence and Harmful to Patients
Manuel Thoma, Laura Froehlich, Daniel B. R. Hattesohl, et al.
Medicina (2023) Vol. 60, Iss. 1, pp. 83-83
Open Access | Times Cited: 13

A systematic review of quantitative EEG findings in Fibromyalgia, Chronic Fatigue Syndrome and Long COVID
Bárbara Silva-Passadouro, A. Tamašauskas, Omar Khoja, et al.
Clinical Neurophysiology (2024) Vol. 163, pp. 209-222
Open Access | Times Cited: 4

Illness presentation and quality of life in myalgic encephalomyelitis/chronic fatigue syndrome and post COVID-19 condition: a pilot Australian cross-sectional study
Breanna Weigel, Natalie Eaton-Fitch, Kiran Thapaliya, et al.
Quality of Life Research (2024) Vol. 33, Iss. 9, pp. 2489-2507
Open Access | Times Cited: 4

Impact of COVID-19 on myalgic encephalomyelitis/chronic fatigue syndrome-like illness prevalence: A cross-sectional survey
Mariah S. Wood, Nicole Halmer, Jeanne Bertolli, et al.
PLoS ONE (2024) Vol. 19, Iss. 9, pp. e0309810-e0309810
Open Access | Times Cited: 4

Potential Beneficial Effects of Naringin and Naringenin on Long COVID—A Review of the Literature
Siqi Liu, Mengli Zhong, Hao Wu, et al.
Microorganisms (2024) Vol. 12, Iss. 2, pp. 332-332
Open Access | Times Cited: 3

Designing and optimizing clinical trials for long COVID
Julia Moore Vogel, Beth Pollack, E. G. Spier, et al.
Life Sciences (2024) Vol. 355, pp. 122970-122970
Open Access | Times Cited: 3

Low-dose naltrexone use for the management of post-acute sequelae of COVID-19
Hector Bonilla, Lü Tian, Vincent C. Marconi, et al.
International Immunopharmacology (2023) Vol. 124, pp. 110966-110966
Open Access | Times Cited: 9

Pediatric and adult patients with ME/CFS following COVID-19: A structured approach to diagnosis using the Munich Berlin Symptom Questionnaire (MBSQ)
Laura-Carlotta Peo, Katharina Wiehler, Johannes Paulick, et al.
European Journal of Pediatrics (2023) Vol. 183, Iss. 3, pp. 1265-1276
Open Access | Times Cited: 9

Reduced exercise capacity, chronotropic incompetence, and early systemic inflammation in cardiopulmonary phenotype Long COVID
Matthew S. Durstenfeld, Michael J. Peluso, Punita Kaveti, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 12

Applying Lessons From Rheumatology to Better Understand Long COVID
Don L. Goldenberg
Arthritis Care & Research (2023) Vol. 76, Iss. 1, pp. 49-56
Closed Access | Times Cited: 7

Gut Microbiota and Mitochondria: Health and Pathophysiological Aspects of Long COVID
Laura Marinela Ailioaie, Constantin Ailioaie, Gerhard Litscher
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17198-17198
Open Access | Times Cited: 6

The importance of estimating prevalence of ME/CFS in future epidemiological studies of long COVID
Anna D. Grabowska, Francisco Westermeier, Luís Nacul, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 5

Interventions for the management of post COVID-19 condition (long COVID): Protocol for a living systematic review & network meta-analysis
Dena Zeraatkar, King‐Hwa Ling, Sarah Kirsh, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1

Post-COVID-19 syndrome: When an acute infection causes a chronic illness
Olga Helena Hernández Ortiz, Andrés Felipe Naranjo Ramírez, Andrea Sierra Ramírez, et al.
Acta Colombiana de Cuidado Intensivo (2024) Vol. 24, Iss. 4, pp. 387-397
Closed Access | Times Cited: 1

Social impact of brain fog and analysis of risk factors: Long COVID in Japanese population
Lisa Shigematsu, Ryusei Kimura, Hideki Terai, et al.
Annals of Clinical and Translational Neurology (2024) Vol. 11, Iss. 8, pp. 2188-2200
Open Access | Times Cited: 1

Scroll to top